Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies.
Morgan
K
K
Department of Cardiology, Royal Postgraduate Medical School, Hammersmith Hospital, London.
D000804:Angiotensin II / Q000378:metabolism*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D004730:Endothelium, Vascular / Q000378:metabolism; D015870:Gene Expression; D006333:Heart Failure / Q000378:metabolism*; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D007703:Peptidyl-Dipeptidase A / Q000235:genetics / Q000378:metabolism*; D012084:Renin-Angiotensin System
D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A